Medical Device San Francisco
Resume:
Anthony J. Marshall
*** ******** **., *** *********, CA 94131
***********@*****.***
EDUCATION
UNIVERSITY OF SAN FRANCISCO, J.D.
School of Law, May 2009.
Earned Intellectual Property Law and Technology Certificate with honors
(G.P.A. 3.77).
Received honors for 2008-2009 (G.P.A. 4.0) and 2007-2008 (G.P.A. 3.4)
school years.
C.A.L.I. Award for Excellence in Patent Licensing, Spring 2009.
CORNELL UNIVERSITY, M.S.
Department of Microbiology & Immunology, August 1998.
Research received a grant from the National Institutes of Health.
Completed thesis titled The Role of Inflammatory Cytokines in Toxoplasma
gondii Infections.
Collaborated on characterizing immune responses to dual Th1 and Th2
infections.
University of California, Santa Barbara, B.S.
Biological Sciences, June 1995.
BAR ADMISSIONS
CALIFORNIA (Bar No. 270744)
U.S. PATENT AND TRADEMARK OFFICE (Registration No. 56406)
EXPERIENCE
King & Spalding LLP, Redwood Shores, May 2008-December 2009.
Law Clerk and Summer Associate, Patent Prosecution Group. Prepared
responses to U.S.P.T.O. office actions for clients in the fields of
biotechnology, drug delivery, and medical devices. Drafted a continuation
application for a medical device client. Prepared patentability analysis
for client in the pharmaceutical industry.
THE J. DAVID GLADSTONE INSTITUTE, UCSF-Mission Bay, August 2008-May 2009.
Legal Extern, Intellectual Property and Technology Transfer
Department. Assisted in the preparation of redlines for licensing and
collaboration agreements with pharmaceutical and biotechnology
companies. Participated in conference calls with outside patent
prosecution counsel. Researched and prepared comprehensive memorandum
on California's Prop 71-Stem Cell Initiative.
Bozicevic, Field, & Francis LLP, Palo Alto, May 2007-July 2007.
Summer Associate. Prepared responses to U.S.P.T.O. office actions for
biotechnology, bioinformatics, biopharmaceutical, and pharmaceutical
clients. Performed legal research regarding 35 U.S.C. 101 lack of
utility rejection for a biopharmaceutical patent. Prepared utility
analysis of a biopharmaceutical patent portfolio and portions of an
invalidity opinion in anticipation of litigation. Drafted appeal brief to
the Board of Patent Appeals and Interferences for a bioinformatics client.
TOWNSEND AND TOWNSEND AND CREW LLP, Palo Alto, January 2006-August 2006.
Patent Prosecution Paralegal, Patent Prosecution and Counseling Group.
Prepared prosecution documents for filing with U.S.P.T.O. Managed
prosecution docket. Researched and prepared materials for new client
pitches.
COOLEY GODWARD LLP, San Francisco, October 2002-January 2006.
Paralegal/Patent Specialist, Patent Prosecution and Intellectual Property
Groups. Assisted in the preparation of provisional patent application for
exercise aid. Prepared Information Disclosure Statements for filing with
U.S.P.T.O. Managed and assisted in complex litigation matters.
Coordinated document productions, prepared expert and lay witnesses for
deposition, managed databases, and drafted privilege logs. Lead paralegal
for technical tutorial and claim construction hearing in semiconductor
patent litigation and paralegal in trademark infringement trial.
SEDGWICK, DETERT, MORAN & ARNOLD LLP, San Francisco, October 2000-
October 2002.
Legal Assistant, Environmental and Toxic Tort Litigation Group. Assisted
on various complex litigation matters involving ground water contaminates.
Managed document production, witness interviews and court filings,
researched assignments in toxicology, hydrogeology, air quality and
emissions. Lead paralegal in ten-month trial, prepared witness and expert
for trial, testimony summaries, drafted court documents, prepared trial
exhibits, and coordinated with court clerk.
THE J. DAVID GLADSTONE INSTITUTE, UCSF, January 1999-October 2000.
Research Associate II, Laboratory of Dr. Israel Charo. Conducted research
to characterize biology of novel CX3C chemokine Fractalkine.
GENITOPE CORPORATION, Redwood City, September 1998-December 1998.
Research Technician. Conducted research on patient specific cell lines
producing tumor-derived antibody for individuals with B-cell Non-Hodgkin's
Lymphoma.
Publications
A. J. Marshall, L. Rosa-Brunet, A. Alcaraz, Y. A. Van Gessel, E. J.
Pearce, and E. Y. Denkers. "Toxoplasma gondii and Schistosoma
mansoni Synergize to Promote Hepatocyte Dysfunction Associated with
High Levels of Plasma TNF-( and Early Death in C57BL/6 Mice." J.
Immunol. 163:2089-209 (1999).
S. Bliss, A. J. Marshall, Y. Zhang, and E. Y. Denkers. "Chemokines
Macrophage-Inflammatory Protein-1( and -1( in Response to Toxoplasma
gondii Antigen." J. Immunol. 162:7369-7375 (1999).
A. J. Marshall, and E. Y. Denkers. "Toxoplasma gondii Triggers
Granulocyte-Dependent Cytokine-Mediated Lethal Shock in D-Galactosamine-
Sensitized Mice." Infect. Immun. 66:1325-1333 (1998).
E. Y. Denkers, and A. J. Marshall. "Neutrophils as a Source of
Immunoregulatory Cytokines During Microbial Infection." The Immunologist.
6:116-120 (1998).
PROFESSIONAL AFFILIATIONS
San Francisco Intellectual Property Association (SFIPLA)
Silicon Valley Intellectual Property Association (SVIPLA)
Intellectual Property Law Section of American Bar Association (ABA-IPL)
American Intellectual Property Law Association (AIPLA)
The Bar Association of San Francisco (BASF)
Contact this candidate